ImageneBio (IMA) Operating Leases (2021 - 2024)
Historic Operating Leases for ImageneBio (IMA) over the last 4 years, with Q3 2024 value amounting to $4.5 million.
- ImageneBio's Operating Leases fell 4427.27% to $4.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.5 million, marking a year-over-year decrease of 4427.27%. This contributed to the annual value of $7.2 million for FY2023, which is 8959.6% up from last year.
- ImageneBio's Operating Leases amounted to $4.5 million in Q3 2024, which was down 4427.27% from $5.4 million recorded in Q2 2024.
- In the past 5 years, ImageneBio's Operating Leases registered a high of $8.0 million during Q3 2023, and its lowest value of $3.1 million during Q2 2023.
- Its 4-year average for Operating Leases is $5.2 million, with a median of $5.1 million in 2021.
- As far as peak fluctuations go, ImageneBio's Operating Leases soared by 9388.59% in 2023, and later tumbled by 4427.27% in 2024.
- Over the past 4 years, ImageneBio's Operating Leases (Quarter) stood at $5.1 million in 2021, then fell by 26.25% to $3.8 million in 2022, then soared by 89.6% to $7.2 million in 2023, then tumbled by 37.73% to $4.5 million in 2024.
- Its last three reported values are $4.5 million in Q3 2024, $5.4 million for Q2 2024, and $6.3 million during Q1 2024.